The Motley Fooltrump news update How Becoming President Cost Trump $3.75 MillionThe Motley Fool - Sean Williams Putting politics aside, President Trump is a groundbreaker in the Oval Office. Never before had the American public elected someone with no political …
Seeking AlphaInvesting J&J files U.S. application for expanded use of TremfyaSeeking Alpha - Douglas W. House Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceuticals has filed a supplemental marketing application with the FDA seeking approval to use TREMFYA …
Seeking AlphaOpioids $8B in opioid damage demanded from J&J, McKessonSeeking Alpha - Yoel Minkoff Johnson & Johnson (NYSE:JNJ), McKesson (NYSE:MCK) and other opioid makers and distributors face demands they pay as much as $8B to cover fallout from …
Global Citizen Festival Global Citizen Festival New York 2019globalcitizen.org - www.globalcitizen.org Citi Citi enables progress around the world by addressing and financially supporting societal challenges that impact our clients and communities. We …
Climate Why 'Generation Earth' Is Rising Upglobalcitizen.org - By Greg Benchwick, author of the children's book Martha, and communications specialist at the United Nations Development Programme Put quite simply, we are failing humanity. We are headed off a cliff and nobody seems to care. To save humanity and save our world, we need to …
Opinion The opioid crisis: A 20-year conspiracy against patients.washingtonexaminer.com - Kelly O'Connor Purdue Pharma, the maker of OxyContin, may have been the prime mover in the Big Bang of opioids in the 1990s, when doctors were aggressively treating …
The Wall Street Journal.added this to MarketsInvesting Opioid Relief Rally Is Likely to StallThe Wall Street Journal. - Charley GrantMomentum in settlement talks to resolve opioid litigation has spurred a stock market rally, but the danger for investors is far from over. OxyContin maker Purdue Pharma has secured support from 23 states
NJ.comadded this to New Jersey newsPurdue Pharma Major opioid company has agreed to tentative $12B settlement. Why N.J. may not get a penny of it.nj.com - Brent Johnson The maker of OxyContin reached a tentative multi-billion-dollar settlement Wednesday with about half the states and local governments suing the …
CheddarInnovation How JLABS Fuels Innovation in HealthcareCheddar Melinda Richter, global head of JLABS at Johnson & Johnson Innovation, joins ChedHER to discuss how JLABS provides entrepreneurs and startups with …
Law Afternoon Briefs: Judge threatens to toss prison officials in hot cells; $37M award in baby powder suitabajournal.com - By Debra Cassens Weiss Texas corrections chief testifies after judge threatens to lock up officials in hot prisons Texas Department of Criminal Justice Executive Director …
Forbesadded this to TechnologyChina Facing Pressure, Multinationals In China Eye Incubators, Accelerators For An EdgeForbes - Russell Flannery“Johnson & Johnson has deep roots in China with an innovation footprint dating back nearly four decades,” Paul Stoffels, chief scientific officer of Johnson & Johnson, said recently in Shanghai Photographer:
Patchadded this to New York City, NY PatchNew York City QNS Woman Says Johnson & Johnson Baby Powder Caused Cancer: SuitPatch - Kathleen Culliton FLUSHING, QUEENS — A Queens woman says Johnson & Johnson baby powder gave her cancer in a new lawsuit, one of thousands the company is facing over …
Climate Why These Youth Activists Are 'All in for Climate Action'globalcitizen.org - By Rebecca Freitag and Fernando Contreras Ramirez, leaders of the youth movement All in for Climate Action "We believe a global crisis needs a global response." Over the course of just a few months, young people from around the world have united under the …
Asbestos Johnson & Johnson hit with $37.3M verdict in NJ talcum powder caseapp.com - Michael L. Diamond A Middlesex County jury Wednesday ordered Johnson & Johnson to pay a total of $37.3 million to four sets of plaintiffs who said they developed …
Forbesadded this to BusinessAcetaminophen J&J Shares Recover Amid $571 Million Fine, But Its Reputation May Never RecoverForbes - ForresterJohnson & Johnson Medical Products company in Markham, Ontario, a division of Johnson & Johnson Inc. Earlier this month, an Oklahoma court ordered Johnson & Johnson to pay $571 million for involvement
Sanofi J&J's Ponesimod Superior to Aubagio in Relapsing MS Patientsyahoo.com - Zacks Equity Research Janssen, a subsidiary of Johnson & Johnson JNJ, announced that its pipeline candidate, ponesimod demonstrated superior efficacy to Sanofi’s SNY …
Medicine J&J ordered to pay $37.3M to 4 mesothelioma plaintiffs in New Jerseyfiercepharma.com - Eric Sagonowsky Johnson & Johnson is defending itself on multiple legal fronts, and Wednesday the drug giant took another loss in its talc powder litigation. A jury …
Law Johnson & Johnson Hit With $37.3M Talc Verdict in New Jerseylaw.com - Amanda Bronstad The verdict, in a trial of four people alleging Johnson & Johnson's talcum powder products caused mesothelioma, comes after the judge struck the …
Seeking AlphaAcetaminophen FDA OKs Elite Pharma's generic Tylenol with CodeineSeeking Alpha - Mamta Mayani The FDA approves Elite Pharmaceuticals' (OTCQB:ELTP) generic version of Johnson & Johnson's Tylenol with Codeine (acetaminophen and codeine …
Opioids The opioid epidemic reckoning is happening — kind ofyahoo.com - Adriana Belmonte Although opioid addiction has been impacting the U.S. for decades, it was only recently that pharmaceutical companies started to be held accountable …
Law Afternoon Briefs: New win for flag burner in SCOTUS case; Johnson Johnson seeks mistrial for stricken closingabajournal.com - By Debra Cassens Weiss • Home • Daily News • Afternoon Briefs: New win for flag burner… Afternoon Briefs: New win for flag burner in SCOTUS case; Johnson & Johnson seeks mistrial …
Forbesadded this to TechnologyProstate Johnson & Johnson's $3.5 Billion Prostate Cancer Drug Sales At Risk?Forbes - Trefis TeamThis is Listerine, a Johnson & Johnson product, on display at a market in Pittsburgh Nov. 14, 2018. (AP Photo/Gene J. Puskar) Johnson & Johnson (NYSE:JNJ) is the leader in the prostate cancer hormonal
Employment Johnson & Johnson to consolidate Bridgewater, Raritan facilitiesmycentraljersey.com - Mike Deak BRIDGEWATER – Johnson & Johnson will consolidate its facilities here and in Raritan Borough in 2020. A company spokesman said most of the employees at …
Common Dreamsadded this to Common Dreams OpEdsRalph Waldo Emerson Why Would We Trust Plutocrats to Save Us From Plutocracy?commondreams.org Ralph Waldo Emerson once wrote of being leery of a loud-talking huckster who visited his home: "The louder he talked of his honor, the faster we …
Law J&J Moves for Talc Mistrial After Judge Strikes Entire Closing Argumentlaw.com - Amanda Bronstad Johnson & Johnson has moved for a mistrial in a high-profile talc trial after a New Jersey judge struck the closing argument of its attorney, Diane …
BloombergBusiness J&J to Pay $37.2 Million to Group Blaming Powder for CancersBloomberg - Jef Feeley Johnson & Johnson must pay at least $37.2 million to four consumers who blamed asbestos-tainted talc for their cancers in the company’s latest loss …
The TakeawayOpioids How States Are Holding Opioid Manufacturers and Distributors Accountablewnycstudios.org The United States continues to struggle with opioid addiction. Nationwide, more than 130 people die every day from an opioid overdose. Now, states …
FlipboardIcon version of the Flipboard logoResearch Reach3 Taps Benoit To Lead Its LA Officemediapost.com - Steve McClellan Market research consultancy Reach3 Insights has appointed Melva Benoit as head of media and entertainment, a new role at the firm. Benoit, who has …
PPeak Bggradded this to Biotech InvestingInvesting Johnson & Johnson's Definitive Tests (Part 1)Seeking Alpha - Out of Ignorance Johnson & Johnson (JNJ) has accumulated an array of adverse jury awards based on sundry liability claims. This article investigates this phenomenon …
Seeking Alphaadded this to Breaking NewsInvesting Purdue Pharma nearing partial settlement of opioid casesSeeking Alpha - Douglas W. House Reuters reports that OxyContin maker Purdue Pharma is close to a partial settlement to resolve many of the outstanding lawsuits related to its role …
